Curis to Present at Upcoming Healthcare Conferences in April [Yahoo! Finance]
Curis, Inc. (CRIS)
Last curis, inc. earnings: 11/1 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.curis.com
Company Research
Source: Yahoo! Finance
for the treatment of cancer, today announced that James Dentzer , President and Chief Executive Officer of Curis, will participate at the 23 rd Annual Needham Virtual Healthcare Conference being held on April 8 - 11, 2024. Presentation details are as follows: Format: Company Presentation Date: Monday, April 8, 2024 Time: 12:45 PM ET A live webcast and archived replay will be available and can be accessed here or on the Events & Presentations section of Curis's website. About Curis, Inc. Curis is a biotechnology company focused on the development of emavusertib, an orally available, small molecule IRAK4 inhibitor. Emavusertib is currently undergoing testing in the Phase 1/2 TakeAim Lymphoma study in patients with relapsed/refractory primary central nervous system lymphoma (PCNSL) in combination with the BTK inhibitor ibrutinib, as a monotherapy in the Phase 1/2 TakeAim Leukemia study in patients with relapsed/refractory acute myeloid leukemia (AML) and relapsed/refractory h
Show less
Read more
Impact Snapshot
Event Time:
CRIS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRIS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRIS alerts
High impacting Curis, Inc. news events
Weekly update
A roundup of the hottest topics
CRIS
News
- Strength Seen in Curis (CRIS): Can Its 19.5% Jump Turn into More Strength? [Yahoo! Finance]Yahoo! Finance
- Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PR Newswire
- Curis to Present at Upcoming Healthcare Conferences in AprilPR Newswire
- SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Curis, Inc. (NASDAQ: CRIS)PR Newswire
- Curis, Inc. (NASDAQ:CRIS) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
CRIS
Earnings
- 2/8/24 - Miss
CRIS
Sec Filings
- 4/15/24 - Form SC
- 4/15/24 - Form EFFECT
- 4/10/24 - Form ARS
- CRIS's page on the SEC website